{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:29:43Z","timestamp":1783985383889,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.otc.2021.12.005","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:06:39Z","timestamp":1646399199000},"page":"305-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prolactinoma"],"prefix":"10.1016","volume":"55","author":[{"given":"Sameah A.","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack P.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","article-title":"Prolactinomas","volume":"44","author":"Glezer","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s12020-014-0369-9","article-title":"Surgical treatment of prolactinomas: cons","volume":"47","author":"Bloomgarden","year":"2014","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000156116","article-title":"Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists","volume":"89","author":"Passos","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.otc.2021.12.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02688697.2021.1903389","article-title":"Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature","volume":"30","author":"Milton","year":"2021","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.otc.2021.12.005_bib6","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1016\/j.wneu.2018.08.068","article-title":"Clinical and radiographic characteristics related to hyperprolactinemia in nonfunctioning pituitary adenomas","volume":"119","author":"Park","year":"2018","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/jcem-72-2-287","article-title":"Dynamics of pulsatile prolactin release during the postpartum lactational period","volume":"72","author":"Nunley","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF03347299","article-title":"Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect","volume":"21","author":"Petakov","year":"1998","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"12","key":"10.1016\/j.otc.2021.12.005_bib9","article-title":"Hyperprolactinaemia","volume":"8","author":"Samperi","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"10","key":"10.1016\/j.otc.2021.12.005_bib10","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","article-title":"Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas","volume":"84","author":"Webb","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12020-019-02029-1","article-title":"Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up","volume":"66","author":"Lv","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.otc.2021.12.005_bib12","first-page":"140052","article-title":"Synchronous GH- and prolactin-secreting pituitary adenomas","volume":"2014","author":"Rahman","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.otc.2021.12.005_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-015-0006-4","article-title":"Management of macroprolactinomas","volume":"1","author":"Tirosh","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7326\/0003-4819-105-2-238","article-title":"Pituitary tumors secreting growth hormone and prolactin","volume":"105","author":"Melmed","year":"1986","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-68-2-412","article-title":"The natural history of untreated hyperprolactinemia: a prospective analysis","volume":"68","author":"Schlechte","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"13","key":"10.1016\/j.otc.2021.12.005_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","article-title":"Clinical practice. Prolactinomas","volume":"362","author":"Klibanski","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.otc.2021.12.005_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF03347092","article-title":"Resistant prolactinomas","volume":"34","author":"Vasilev","year":"2011","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of medically refractory prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"7","key":"10.1016\/j.otc.2021.12.005_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4158\/EP-2018-0321","article-title":"The effect of raloxifene on serum prolactin level in patients with prolactinoma","volume":"25","author":"Choudhary","year":"2019","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.otc.2021.12.005_bib21","first-page":"1369","article-title":"Dopamine agonist-resistant prolactinomas","volume":"114","author":"Oh","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos Nunes","year":"2011","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-019-00989-1","article-title":"Dopamine agonists in prolactinomas: when to withdraw?","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","article-title":"Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis","volume":"95","author":"Dekkers","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.otc.2021.12.005_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MED.0b013e328347c94a","article-title":"Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia","volume":"18","author":"Pereira","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"10.1016\/j.otc.2021.12.005_bib26","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jocn.2013.02.027","article-title":"Pituitary apoplexy associated with cabergoline therapy","volume":"20","author":"Chng","year":"2013","journal-title":"J\u00a0Clin Neurosci"},{"issue":"6","key":"10.1016\/j.otc.2021.12.005_bib27","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2012.4.FOCUS1268","article-title":"Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature","volume":"32","author":"Lam","year":"2012","journal-title":"Neurosurg focus"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib28","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERP-18-0069","article-title":"Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology","volume":"6","author":"Steeds","year":"2019","journal-title":"Echo Res Pract"},{"issue":"10","key":"10.1016\/j.otc.2021.12.005_bib29","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1210\/jc.2007-1403","article-title":"Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline","volume":"93","author":"Colao","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib30","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1210\/clinem\/dgaa882","article-title":"Incidence of cabergoline-associated valvulopathy in primary care patients with prolactinoma using hard cardiac endpoints","volume":"106","author":"Stiles","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib31","first-page":"105","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. a systematic review and meta-analysis","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2021.12.005_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-021-01168-x","article-title":"Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas","author":"Park","year":"2021","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","article-title":"Surgical treatment of microprolactinomas: pros","volume":"47","author":"Salvatori","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1042-3680(02)00090-6","article-title":"Role of surgery in the treatment of microprolactinomas","volume":"14","author":"Couldwell","year":"2003","journal-title":"Neurosurg Clin N Am"},{"issue":"4","key":"10.1016\/j.otc.2021.12.005_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","article-title":"Pituitary hormonal loss and recovery after transsphenoidal adenoma removal","volume":"63","author":"Fatemi","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.otc.2021.12.005_bib36","article-title":"Pituitary Society Delphi survey: an international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas","author":"Tritos","year":"2021","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.otc.2021.12.005_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.beem.2009.05.002","article-title":"Surgical treatment of pituitary tumours","volume":"23","author":"Buchfelder","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2021.12.005_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-211-72283-1_4","article-title":"Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery","volume":"33","author":"Cappabianca","year":"2008","journal-title":"Adv Tech Stand Neurosurg"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib39","first-page":"578","article-title":"Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas","volume":"111","author":"Cavallo","year":"2009","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/lary.22475","article-title":"Endoscopic skull base reconstruction of large dural defects: a systematic review of published evidence","volume":"122","author":"Harvey","year":"2012","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib41","first-page":"861","article-title":"Evolution of the graded repair of CSF leaks and skull base defects in endonasal endoscopic tumor surgery: trends in repair failure and meningitis rates in 509 patients","volume":"130","author":"Conger","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib42","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.4158\/ACCR-2018-0267","article-title":"Cystic prolactinoma: a surgical disease?","volume":"5","author":"Bhavsar","year":"2019","journal-title":"AACE Clin Case Rep"},{"issue":"10","key":"10.1016\/j.otc.2021.12.005_bib43","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2016-2008","article-title":"Dopamine agonists can reduce cystic prolactinomas","volume":"101","author":"Faje","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.otc.2021.12.005_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nec.2019.05.010","article-title":"The role of surgery in the management of prolactinomas","volume":"30","author":"Donoho","year":"2019","journal-title":"Neurosurg Clin N Am"},{"issue":"4","key":"10.1016\/j.otc.2021.12.005_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11102-018-0888-0","article-title":"Management of cystic prolactinomas: a review","volume":"21","author":"Nakhleh","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1262-8","article-title":"Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy","volume":"117","author":"Ding","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"1","key":"10.1016\/j.otc.2021.12.005_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(87)90496-7","article-title":"Primary radiotherapy of prolactinomas. Eight- to 15-year follow-up","volume":"83","author":"Mehta","year":"1987","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"10.1016\/j.otc.2021.12.005_bib49","first-page":"10","article-title":"Gamma knife radiosurgery as a primary treatment for prolactinomas","volume":"93","author":"Pan","year":"2000","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1227\/01.NEU.0000223445.22938.BD","article-title":"Gamma Knife radiosurgery for medically and surgically refractory prolactinomas","volume":"59","author":"Pouratian","year":"2006","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib51","first-page":"303","article-title":"Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.otc.2021.12.005_bib52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.otc.2021.12.005_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11060-009-9832-5","article-title":"Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife","volume":"92","author":"Jagannathan","year":"2009","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.otc.2021.12.005_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-018-2801-0","article-title":"Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery","volume":"138","author":"Forster","year":"2018","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.otc.2021.12.005_bib55","doi-asserted-by":"crossref","DOI":"10.1530\/EC-18-0255","article-title":"Clinical and biochemical characteristics of patients presenting with pituitary apoplexy","author":"Abbara","year":"2018","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1016\/j.otc.2021.12.005_bib56","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4103\/2230-8210.100656","article-title":"Spontaneous reduction of prolactinoma post cabergoline withdrawal","volume":"16","author":"Venkatesh","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.otc.2021.12.005_bib57","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1210\/jc.2007-0373","article-title":"Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features","volume":"92","author":"Suliman","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.otc.2021.12.005_bib58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/000348940711601206","article-title":"Risk of meningitis with cerebrospinal fluid rhinorrhea","volume":"116","author":"Daudia","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"10.1016\/j.otc.2021.12.005_bib59","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/alr.22136","article-title":"Beta-2 transferrin is detectable for 14\u00a0days whether refrigerated or stored at room temperature","volume":"8","author":"Zervos","year":"2018","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521002413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521002413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T08:21:39Z","timestamp":1672388499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666521002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0030666521002413"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2021.12.005","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactinoma","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}